Belgian parties seek pharma revamp focused on talent, innovation, and digital transformation

EURACTIV - The future of Belgium's pharmaceutical industry is under scrutiny as competition challenges Belgian success. Leading Belgian politicians discussed revamping pharma's road map in a recent conversation with Euractiv. Read more

"Incentives for R&D at the Flemish level and sharing medical data are essential to improve competitiveness with the US and Asia." [Shutterstock / Sergey Kolesnikov]